Report of the Study Group on Utilization of Big Data in Medical and Health Fields vol.5
Masami Morita ( The Office of Pharmaceutical Industry Research Senior Researcher)
Takayuki Sasaki（ The Office of Pharmaceutical Industry Research Senior Researcher)
Yasuhiko Nakatsuka ( The Office of Pharmaceutical Industry Research Senior Researcher)
(Published in June 2020)
Our study group has continued to conduct research and studies on the use of big data in the medical health field since FY2015, and has produced an annual report; in FY2019, we are focusing on the "data elements" that are the source of value creation. In a data-driven society, the formation of a "data ecosystem" in which data utilization develops autonomously and continuously is important, and the realization of such an ecosystem is predicated on the creation of data that can actually be used and on the increased accessibility of data. From this perspective, we conducted a survey and research from the viewpoint of how to realize the creation of a "data ecosystem," with a particular focus on the elements of data "quality" and "accessibility.
The main players in the medical healthcare "data ecosystem" are "digitized patient and consumer data. Starting with medical information such as electronic medical records and image data, a wide variety of information including genome information, personal health records (PHR) such as health and medical checkup data, and lifestyle and behavioral data will be covered. In order for these data to be generated as usable data, it is necessary to ensure the quality of the data according to the purpose of use, enhance the possibility of linkage and interoperability, improve the accessibility of the data, and establish an environment in which the value and results generated from the data are promptly fed back.
From this perspective, we have summarized three perspectives as key measures to further advance the realization of data-driven healthcare. For more detailed information, please refer to the full report.